From: Interventions for renal vasculitis in adults. A systematic review
Study Id | Inclusion criteria | Exclusion criteria |
---|---|---|
Cole 1992 | RPGN of undefined aetiology (idiopathic or post infectious disease) with specific pathologic criteria. | Cellular crescents in < 50% non-obsolescent glomeruli. Evidence of serious infection or active ulcer disease. |
 | Adults (16-75 y), normal sized kidneys SCr > 170 μmol/L and/or increasing by 44 μmoles/l per wk. |  |
 | No evidence of systemic disease or anti-glomerular basement membrane antibody-induced disease. |  |
 | Renal biopsy within 5 days of trial entry |  |
Jayne 2007 | Biopsy-proven ANCA-associated necrotizing GN with acute kidney failure (SCr > 500 μmol/L) | Age <18 or > 80 years. |
 |  | Inadequate contraception; pregnancy; previous malignancy; hepatitis B antigenaemia or hepatitis C antibody or HIV infection; other multi-system autoimmune disease; circulating anti-GBM antibody or linear staining of GBM on histology; life-threatening non-renal manifestations of vasculitis. |
 |  | Dialysis for > 2 weeks before entry; creatinine >200 uM more than 1 year before entry. > 2 weeks treatment with CPA or AZA; > 500 mg of IV methylprednisolone; plasma exchange within the preceding year; >3 months treatment with oral prednisolone; allergy to study medications. |
Glockner 1988 | RPGN with >70% crescents on renal biopsy. CrCl < 50 ml/min. Urine output > 200 ml/24 h. | Anti-GBM disease, life threatening conditions, contraindications to immunosuppression, previous treatment with AZA or CPA for >14 days. |
Mauri 1985 | Histologically proven crescentic GN and rapidly progressive renal impairment. | Less than 60% glomerular involvement, primary glomerulopathies, transplanted kidneys, SLE, HSP. |
Pusey 1991 | Focal necrotizing GN with crescents (Wegener's granulomatosis, systemic vasculitis, polyarteritis, idiopathic RPGN) | Anti-GBM disease, SLE, Henoch-Schonlein Purpura, chronic GN Previously treated with IV MP, oral CPA or PE |
Rifle 1980 | New onset RPGN with > 50% glomerular crescents. | Goodpasture's syndrome; IgA nephropathies; SLE; systemic disease. |